cho_logo_symbol_border
  • (800) 266-7207 | 30 Wall St. 8th Floor New York, NY 10005
  • Mon - Fri: 8:00 am - 5:00 pm

Clear Health Pass NIPT

Easing minds and providing gentle care one test at A time.

Your patient’s pregnancy journey should be as stress-free and worry-free as possible. Premier Medical Laboratory Services offers Clear Health Pass Non-invasive Prenatal Testing (NIPT) for your patients to get the most sensitive and specific screening option during prenatal care. With the highest detection rate and lowest false positive rate, your patients can rest assured in the results they receive. Schedule a call today with one of our experts for more information on our Clear Health Pass NIPT testing options.

Simple. Safe. Stress-Free.

Welcoming a baby is one of the greatest treasures in life. With 97% of babies born healthy, there is still a 3% chance of abnormalities. Clear Health Pass NIPT can help those families prepare for the otherwise unexpected with just 1 tube of maternal blood. Patients receive quick and easy results within 4 – 6 business days. Clear Health Pass NIPT is available for all pregnant women regard-less of age, risk, single or multiple births.

Stress and worry free, patients can see results within 4 – 6 business days and only require 1 tube of maternal blood.

Clear Health Pass NIPT is an option for all pregnant women, regardless of age, risk, single or multiple births.

Contact@Clearhealthpass.com

(800) 266-7207 EXT 717

30 Wall St. 8th floor New York, NY 10005

Clear Health Pass as Specifications Developer

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

As a Specification Developer, the Company may also arrange for the manufacturing of devices labeled with another establishment’s
name by a contract manufacturer.

The distribution of collection kits, specimen transport, marketing, test distribution, and actual testing is performed by a high-complexity Clinical Laboratory Improvement Amendments (CLIA) lab.

All testing conducted by the CLIA lab is compliant with the Centers for Medicare and Medicaid Services (CMS) CLIA Lab Amendments Act.

Disclaimer

Clear Health Pass Safe Harbor Exemption
The information on this website does not constitute an offer to sell or solicitation of an offer to buy securities by anyone in any jurisdiction which would be considered unlawful. Clear Health Pass Holdings, LLC’s offering is under Rule 506(c) of Regulation D and is considered a “safe harbor” for the private offering exemption of Section 4(a)(2) of the Securities Act. To be eligible to receive qualified investment status, you must be an accredited investor as defined by Section 2(15)(ii) of the Securities Act of 1933.

© 2023 Clear Health Pass Holdings™, LLC., All trademark references are trademarks of either the Clear Health Pass Holdings, LLC or their respective owners.

Skip to content